EWA
HAE icon

EverSource Wealth Advisors’s Haemonetics HAE Stock Holding History

EverSource Wealth Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$101K Sell
1,344
-576
-30% -$37K ﹤0.01% 1379
2026
Q1 		$108K Buy
1,920
+211
+12% +$13.7K ﹤0.01% 1382
2025
Q4 		$137K Buy
1,709
+1,343
+367% +$90.2K 0.01% 1152
2025
Q3 		$17.8K Sell
366
-45
-11% -$2.79K ﹤0.01% 2446
2025
Q2 		$30.7K Buy
411
+396
+2,640% +$26.2K ﹤0.01% 1969
2025
Q1 		$953 Sell
15
-49
-77% -$3.33K ﹤0.01% 3244
2024
Q4 		$5K Sell
64
-3
-4% -$241 ﹤0.01% 2346
2024
Q3 		$5.38K Buy
67
+8
+14% +$646 ﹤0.01% 2197
2024
Q2 		$5.31K Sell
59
-6
-9% -$528 ﹤0.01% 2201
2024
Q1 		$5.98K Buy
65
+59
+983% +$4.63K ﹤0.01% 1960
2023
Q4 		$513 Hold
6
– – ﹤0.01% 2518
2023
Q3 		$537 Hold
6
– – ﹤0.01% 2356
2023
Q2 		$511 Hold
6
– – ﹤0.01% 2350
2023
Q1 		$497 Buy
+6
New +$486 ﹤0.01% 2228

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EverSource Wealth Advisors's HAE Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Haemonetics (HAE) stake by 30% in Q2 2026, selling an estimated $37K and leaving 1,344 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #1379.

EverSource Wealth Advisors first reported a position in HAE in Q1 2023 and has held it in 14 quarters since. The position peaked at $137K in Q4 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • EverSource Wealth Advisors held 1,344 shares of Haemonetics worth $101K as of Q2 2026.
  • EverSource Wealth Advisors sold 576 Haemonetics shares in Q2 2026, an estimated $37K.
  • Haemonetics made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #1379 holding.
  • EverSource Wealth Advisors first reported a position in Haemonetics in Q1 2023 and has held it in 14 quarters since.
  • EverSource Wealth Advisors's Haemonetics position peaked at $137K in Q4 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.